Chronic Stroke Study Available!

Impact of Biophoton Energy on Stroke Recovery

—an IRB approved clinical study 

 Listed on (NCT05898334) - click here.

An opportunity for chronic stroke patients: First Institute of All Medicines, a non-profit organization, is to conduct the first of its kind clinical study, which is a triple blinded, placebo-controlled, two-group randomized clinical study to further assess what Biophoton Generators can do for people with chronic stroke.

Be a pioneer for Biophoton Research: In recent years, the field of quantum medicine has witnessed a surge in interest and research. Biophoton Generators have emerged as a promising therapeutic approach among the various modalities. These devices are designed to emit biophotons, or life force energy, which are believed to have potential health benefits for those with unmet medical conditions.

Contributing to Science: Biophoton Generators are based on the concept that living organisms emit and receive photons as a form of intercellular communication. Proponents of Biophoton therapy argue that the application of specific light frequencies can stimulate cellular functions, promote balance, and support the body's natural healing processes. While scientific evidence supporting the special claims is limited, real-world evidence and preliminary studies have shown promising results. Read the most recent scientific publication here.


World’s First Energy Wellness Hotel
139 Pittsburgh Road
Butler, PA 16001

Medical research staff at First Institute of All Medicines will be conducting this study using the research facilities at the Biophoton-powered Tesla MedBed Spa and Wellness center.

Our study participants and their caregiver guests will sleep on a Tesla MedBed, powered by biophoton generators. They will also enjoy our hotel amenities for the length of the study, including a climate-controlled biophoton-energized atmosphere, along with access to our energized pool and gym.

Study Specifics:


  • Participants: 46 volunteers with chronic stroke.
  • Location: Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001.
  • Duration: 4-6 week live-in study in a hotel-like environment. Non-invasive, just sleep on a MedBed powered with biophoton generators. Estimated Study Dates: first participant enrolled as of May 2023 and last participant to complete by Nov 2024.
  • Procedures: Sleep nightly on a bed with Tesla BioHealing Biophoton Generators underneath (or placebo) and complete life quality assessments. Health status information will be collected non-invasively by a medical professional. Those volunteers initially placed in the placebo group will be switched to the Treatment group 2 weeks after verifying the placebo effects. They will be treated for 4 weeks as well.
  • Qualification: There will be a qualification process to participate in this study. If you are interested in participating, please click the link below, or use the contact information below to connect with the research team. You are also welcomed to reach out to us if you would like more specific information about participation.
  • Safety and Technology User Group Size: Our technology has already been used by 30,000+ users. Learn more about safety here.
  • Cost: Qualified study participants with a doctor's stroke diagnosis (and their caregivers) are to stay at the MedBed Center Wellness Hotel free of charge for the length of the study! There will be no cost to participate. Please note that we do not reimburse or pay for travel or food.
  • How do we support stroke patients?
    Click here to search for testimonials and learn about how our technology may support your specific health condition.
  • Apply today—spaces are extremely limited!
    The research team at First Institute of All Medicines/FIAM looks forward to hearing from you! We encourage you to submit an application as soon as possible. You'll find the secure application link below. Also, feel free to have a family member or caregiver assist with your registration process by using our contact information.


Jessica Jackson, Clinical Study Coordinator
First Institute of All Medicines
139 Pittsburgh Road, Butler, PA 16001.

Cell phone: 302-922-2486